3D Ultrasound Support for Hemodialysis Cannulation
Official title: Study of 3D Ultrasound for Support of Hemodialysis Cannulation
Run by Sonavex, Inc. · NCT07891741 · Data updated 2026-11-12
This study tests whether the EchoMap device can help safely cannulate an arm fistula during hemodialysis for adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Sonavex, Inc. Industry-sponsored |
| Locations | 3 sites (Hartford, Connecticut and 2 other locations) |
| Status | Recruiting |
| Started | May 7, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07891741 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 up to 85 with a mature upper-extremity AV fistula cleared for at least one cannulation and either a history of miscannulation or a need for expert cannulation.
✕Probably not a fit
Patients with non-mature fistulas, fistulas not cleared for cannulation, or without cannulation difficulties may not experience direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-arm feasibility study conducted at multiple centers to see if EchoMap-assisted cannulation is safe and effective when used with standard cannulation methods for patients with autologous upper-extremity AV fistulas. The study uses a two-stage design to evaluate feasibility in real-world dialysis settings. Participants are adults with a mature fistula cleared for at least one cannulation and with a history of miscannulation or a need for an expert cannulator. Interventions include EchoMap-assisted cannulation along with the standard of care, under appropriate monitoring. Result data will inform whether EchoMap merits broader testing in future research.
Why it matters
Potential benefit: If successful, EchoMap-assisted cannulation could reduce cannulation-related complications and improve fistula longevity and dialysis efficiency.
How similar studies have gone: Prior studies with similar ultrasound-guided or adjunctive cannulation approaches have shown feasibility; this study adds a dedicated EchoMap feasibility evaluation in a multi-center setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years but \< 85 years of age at the time of informed consent * Subjects who have received an upper extremity autologous arteriovenous fistula, which has been cleared for at least 1-needle cannulation * Subjects have a fistula with a history of miscannulation or requires an expert cannulator or have a new fistula that has not previously been cannulated * Subject is able to sign informed consent and able to participate in all testing associated with this clinical investigation Exclusion Criteria: * Age \<18 years old * Subject unable to sign informed consent. * Subject is breastfeeding, pregnant, or plans to become pregnant * Prisoner or Subject from vulnerable populations as defined in 45 CFR 46. * Subjects that do not have a clinically mature upper extremity AV fistula that is cleared for at least 1-needle cannulation * Subjects that do not have a fistula with a history of miscannulation or requires an expert cannulator or do not have a new fistula that has not previously been cannulated * Subjects that are cannulated through a buttonhole technique * Subjects with a history of poor compliance with the dialysis protocol * Subjects who have suffered an access related injury or underwent access related intervention in the last 2 weeks
Where it's running
-
Hartford Dialysis
Hartford, Connecticut, United States Recruiting -
Greater Waterbury Dialysis
Middlebury, Connecticut, United States Recruiting -
CN Clinical Research
Greenville, South Carolina, United States Recruiting
Study contacts
- Study coordinator: R Del Negro
- Email: rdelnegro@sonavex.com
- Phone: 4438622024
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Italian Registry of Pediatric Dialysis: collecting data from kids on kidney replacement therapy
This registry in Italy tests how collecting epidemiological, clinical, and treatment data from children on dialysis or pre-emptive kidney transplants can help centers share protocols and improve care.
-
Laser acupuncture for fatigue in adults on hemodialysis
This trial tests whether low-level laser acupuncture can reduce fatigue and improve quality of life for adults with end-stage kidney disease who are on regular hemodialysis, compared with a sham treatment.
-
Low-intensity versus standard-intensity continuous dialysis for critically ill adults with acute kidney injury
This will try giving lower-intensity continuous dialysis instead of the usual intensity to adults in intensive care with acute kidney injury to see if kidneys recover just as well with fewer side effects.
-
Epidemiology and care for dialysis in ICU patients with severe acute kidney injury in Latin America
This project will collect and compare data on adults in ICUs across Latin America who need dialysis for severe acute kidney injury to see how they are treated and what outcomes they have.
-
Switching to pegmolesatide for anemia in people on dialysis
This 24-week test will try whether switching dialysis patients whose anemia isn't at goal from rHuEPO to pegmolesatide alone or combined with roxadustat keeps or raises hemoglobin better than continuing rHuEPO.
-
Checking thyroid function in adults on hemodialysis at Sohag University Hospital
This project tests whether routine thyroid blood tests find thyroid problems in adults who have been on regular hemodialysis for at least three months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.